Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy

Mendell JR, Shilling C, Leslie ND et al (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71:304–313 Hoffman E, Brown R, Kunkel L (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928 McDonald C, Abresch R, Carter G et al (1995) Profiles of neuromuscular diseases: Duchenne muscular dystrophy. Am J Phys Med Rehabil 995:S70–S92 Nghiem P, Bello L, Stoughton W et al (2017) Changes in muscle metabolism are associated with phenotypic variation in golden retriever muscular dystrophy. Yale J Biology Med 90:351–360 Timpani C, Hayes A, Rybalka E (2015) Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne muscular dystrophy aetiology. Med Hypotheses 85:1021–1033 Onopiuk B, Wierzbicka K et al (2009) Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts. Biochem Bioph Res Comm 386:463–466 Sharma U, Atri S, Sharma M et al (2003) Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging 21:145–153 Chi H, McKee D et al (1987) Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism 36:761–767 Rando T (2002) Oxidative stress and the pathogenesis of muscular dystrophies. Am J Phys Med Rehabil 81:S175–S186 Birnbaum (1989) Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57:305–315 Rodríguez-Cruz M, Sanchez R, Escobar R et al (2015) Evidence of insulin resistance and other metabolic alterations in boys with Duchenne or Becker muscular dystrophy. Int J Endocrinol 2015:1–8 Olichon-Berthe C, Gautier N, Obberghen E, Marchand-Brustel Y (1993) Expression of the glucose transporter GLUT4 in the muscular dystrophic mdx mouse. Biochem J 291:257–261 Klip A, Sun Y, Chiu T, Foley K (2014) Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation. Am J Physiol Cell Physiol 306:C879–C886 Lund S, Holman GD, Schmitz O, Pedersen O (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc National Acad Sci (USA) 92:5817–5821 Luiken JJ, Glatz JF, Neumann D (2015) Cardiac contraction-induced GLUT4 translocation requires dual signaling input. Trends Endocrinol Metabolism 26:404–410 Nikolaidis LA, Sturzu A, Stolarski C et al (2004) The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61:297–306 Kornegay JN, Tuler SM, Miller DM, Levesque DC (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11:1056–1064 Sharp NJ, Kornegay JN, Van Camp SD et al (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13:115–121 Terrill J, Duong M, Turner R et al (2016) Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the golden retriever muscular dystrophy dog model for Duchenne muscular dystrophy. Redox Biol 9:276–286 Nghiem P, Hoffman E, Mittal P et al (2013) Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. Am J Pathology 183:1411–1424 Kornegay J, Spurney C, Nghiem P et al (2014) Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J 55:119–149 Momose M, Iguchi N, Imamura K et al (2001) Depressed myocardial fatty acid metabolism in patients with muscular dystrophy. Neuromuscul Disord 11:464–469 Nishimura T, Yanagisawa A, Sakata H, Sakata K, Shimoyama K, Ishihara T, Yoshino H, Ishikawa K (2001) Thallium-201 single photon emission computed tomography (SPECT) in patients with Duchenne’s progressive muscular dystrophy. Jpn Circulation J 65:99–105 Perloff JK, Henze E, Schelbert HR (1984) Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 69:33–42 Santacatterina F, Chamorro M, Arenas CN et al (2015) Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases. J Transl Med 13:1–11 Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K (2013) Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics 12:1061–1073 Kemp GJ, Taylor DJ, Dunn SP et al (1993) Cellular energetics of dystrophic muscle. J Neurol Sci 116:201–206 Chen Y-W, Zhao P, Borup R, Hoffman E (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151:1321–1336 Richter E, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017 Garvey WT, Maianu L, Hancock JA et al (1992) Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41:465–475 Garvey WT, Maianu L, Zhu JH et al (1998) Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377–2386 Kornegay JN, Cundiff DD, Bogan JR et al (2003) The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy. Neuromuscul Disord 13:493–500 Daugaard JR, Nielsen JN, Kristiansen S, Andersen JL, Hargreaves M, Richter EA (2000) Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes 49:1092–1095 Pacini G, Bergman R (1986) MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Meth Prog Bio 23:113–122 Howlett KF, Andrikopoulos S, Proietto J, Hargreaves M (2013) Exercise-induced muscle glucose uptake in mice with graded, muscle-specific GLUT-4 deletion. Physiol Rep 1:e00065 Ahmad N, Welch I, Grange R et al (2011) Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice. BMC Musculoskel Dis 12, 12(1) Reinhardt N, Beu M, Vosberg H et al (1999) Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET. J Nucl Med 40:977–985 Zorzano A, Sevilla L, Tomàs E et al (1997) GLUT4 trafficking in cardiac and skeletal muscle: isolation and characterization of distinct intracellular GLUT4-containing vesicle populations. Biochem Soc T 25:968–974 Horie T, Ono K, Nagao K et al (2008) Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol 215:733–742 Markham LW, Brinkmeyer-Langford CL, Soslow JH et al (2017) GRMD cardiac and skeletal muscle metabolism gene profiles are distinct. BMC Med Genet 10:21 DeFronzo RA, Gunnarsson R, Björkman O et al (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II)diabetes mellitus. J Clin Invest 76:149–155 Schnurr TM, Reynolds AJ, Gustafson SJ et al (2014) Conditioning causes an increase in glucose transporter-4 levels in mononuclear cells in sled dogs. Int J Biochem Cell Biology 55:227–231 Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE Jr, Kern PA, Peterson CA (2009) Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296:E1300–E1310 Kornegay JN, Bogan JR, Bogan DJ et al (2011) Golden retriever muscular dystrophy (GRMD): developing and maintaining a colony and physiological functional measurements. Methods Mol Biol 709:105–123